Inovio Pharmaceuticals Inc (INO)
1.87
+0.01
(+0.54%)
USD |
NASDAQ |
Dec 27, 16:00
1.90
+0.03
(+1.60%)
After-Hours: 20:00
Inovio Pharmaceuticals Research and Development Expense (Annual): 86.68M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
Novavax Inc | 737.50M |
Baxter International Inc | 667.00M |
CervoMed Inc | 8.438M |
Leap Therapeutics Inc | 73.23M |
Candel Therapeutics Inc | 24.51M |